United Healthcare, Inc. – Trademark Portfolio
Entity Type: 03
United Healthcare, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SPECTERA and UNITEDHEALTHCARE. The owner is based in Baltimore, MD.
2811 Lord Baltimore Drive
Baltimore, MD 21207
Showing of trademarks Trademarks
Trademark Classifications
United Healthcare, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does United Healthcare, Inc. have?
United Healthcare, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does United Healthcare, Inc. file in?
United Healthcare, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are United Healthcare, Inc.'s most well-known trademarks?
United Healthcare, Inc.'s registered trademark portfolio includes well-known marks such as SPECTERA and UNITEDHEALTHCARE. These are among 2 currently registered trademarks in the portfolio.
What is United Healthcare, Inc.'s trademark registration success rate?
United Healthcare, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.